Overactive bladder (OAB) is a common condition affecting the elderly. The mainstay of treatment for OAB is medical therapy with anticholinergics. However, adverse events have been reported with this class of drugs including cognitive changes
AbstractBackgroundOveractive bladder (OAB) involves a complex set of symptoms with a lifetime preval...
Background: Around 16% of adults have symptoms of overactive bladder (OAB; urgency with frequency an...
Objective: To evaluate and to compare the effectiveness of drugs for overactive bladder. Aims: 1) To...
Overactive bladder (OAB) is a common condition affecting the elderly. The mainstay of treatment for ...
INTRODUCTION AND HYPOTHESIS: To assess cognitive changes in women 12 months after starting anticholi...
Overactive bladder (OAB) is often treated with medications that block the cholinergic receptors in t...
Background: overactive bladder (OAB) affects 17-41% older adults in community dwelled setting. For s...
Context: The cognitive side effects of medications with anticholinergic activity have been documente...
Introduction: The evidence on the impact of bladder antimuscarinics initiation on cognitive function...
Abstract Background Antimuscarinics are often used fo...
Introduction Antimuscarinics should be used with caution in older adults with overactive bladder (OA...
To determine the cognitive and functional consequences of dual use of cholinesterase inhibitors (ChI...
Evidence suggests that the prescription of bladder anticholinergics is increasing. Recent studies ha...
Second-line treatment for overactive bladder (OAB), consists of muscarinic antagonists or β-3 agonis...
The International Continence Society (ICS) defines overactive bladder (OAB) as an association of sym...
AbstractBackgroundOveractive bladder (OAB) involves a complex set of symptoms with a lifetime preval...
Background: Around 16% of adults have symptoms of overactive bladder (OAB; urgency with frequency an...
Objective: To evaluate and to compare the effectiveness of drugs for overactive bladder. Aims: 1) To...
Overactive bladder (OAB) is a common condition affecting the elderly. The mainstay of treatment for ...
INTRODUCTION AND HYPOTHESIS: To assess cognitive changes in women 12 months after starting anticholi...
Overactive bladder (OAB) is often treated with medications that block the cholinergic receptors in t...
Background: overactive bladder (OAB) affects 17-41% older adults in community dwelled setting. For s...
Context: The cognitive side effects of medications with anticholinergic activity have been documente...
Introduction: The evidence on the impact of bladder antimuscarinics initiation on cognitive function...
Abstract Background Antimuscarinics are often used fo...
Introduction Antimuscarinics should be used with caution in older adults with overactive bladder (OA...
To determine the cognitive and functional consequences of dual use of cholinesterase inhibitors (ChI...
Evidence suggests that the prescription of bladder anticholinergics is increasing. Recent studies ha...
Second-line treatment for overactive bladder (OAB), consists of muscarinic antagonists or β-3 agonis...
The International Continence Society (ICS) defines overactive bladder (OAB) as an association of sym...
AbstractBackgroundOveractive bladder (OAB) involves a complex set of symptoms with a lifetime preval...
Background: Around 16% of adults have symptoms of overactive bladder (OAB; urgency with frequency an...
Objective: To evaluate and to compare the effectiveness of drugs for overactive bladder. Aims: 1) To...